Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how ...

Messenger RNA–based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the ...

A new study published on Thursday by Melbourne's Peter Doherty Institute for Infection and Immunity and RMIT University ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...